Monographie - Ipratropium bromide

Ipratropium bromide

Σταθερότητα και συμβατότητα των φαρμάκων

χημική δομή

Βιβλιογραφία : Ipratropium bromide

	τύπος	δημοσίευση
665	εφημερίδα	Blondino, FE, Baker M. Stability of Nebulizer Admixtures. Int J Pharm Compound 2005 ; 9, 4: 323-326.
2550	εφημερίδα	Roberts GW, Rossi S.O.P. Compatibility of nebulizer solutions Aust J Hosp Pharm 1993 ; 23: 35-37.
2635	εφημερίδα	Yamreudeewoh W, Teixeira G, Mayer GE. Stability of levalbuterol in a mixture of levalbuterol and ipratropium nebulizer solution. Hosp Pharm 2008 ; 43, 4: 303-306.
2685	εφημερίδα	Jacobson GA, Peterson GM. Stability of ipratropium bromide and salbutamol nebuliser admixtures. Int J Pharm Pract 1995 ; 3: 169-173.
2770	εφημερίδα	Krämer I, Schwabe A, Lichtinghagen R, Kamin W. Physicochemical compatibility of nebulizable drug mixtures containing dornase alfa and ipratropium and/or albuterol. Pharmazie 2007 ; 62, 10: 760-766.
2774	εφημερίδα	McKenzie J.E, Mario Cruz-Rivera M. Compatibility of Budesonide Inhalation Suspension with Four Nebulizing Solutions. Ann Pharmacotherapy 2004 ; 38: 967-972.
2787	εφημερίδα	Lee TY, Chen CM, Lee CN, Chaing YC. Compatibility and osmolality of inhaled N-acetylcysteine nebulizing solution with fenoterol and ipratropium. Am J Health-Syst Pharm 2005 ; 62, 8: 828-833.
2790	εφημερίδα	Kamin W, Schwabe A, Krämer I. Physicochemical compatibility of fluconasone-17-propionate nebulizer suspension with ipratropium and albuterol nebulizer solutions. Int J COPD 2007 ; 1, 4: 599-607.
2803	εφημερίδα	Bonasia PJ, McVicar WK, Williams B, Ong S. Chemical and physical compatibility of levalbuterol inhalation solution concentrate mixed with budesonide, ipratropium bromide, cromolyn sodium or acetylcysteine sodium. Respiratory Care 2008 ; 683, 12: 1716-1722.
3019	εφημερίδα	Bonasia P, Cook C, Cheng Y et al. Compatibility of arformoterol tartrate inhalation solution with three nebulized drugs. Curr Med Res Opin 2007 ; 23: 2477-2483.
3472	εφημερίδα	Krämer I, Schwabe A, Kamin W. Physikalisch-chemische kompatilibität von Mischinhalationslösungen und suspensionen zur simultanen feuchtinhalationstherapie bei Mukoviszidose Patienten. Krankenhauspharmazie 2007 ; 28, 5: 170-178.
3498	εφημερίδα	Akapo S, Gupta J, martinez E, Mccrea C, Ye L, Roach M Compatibility and aerosol characteristics of formoterol fumarate mixed with other nebulizing solutions. Ann Pharmacotherapy 2008 ; 42, 10: 1416-1424.